These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33672395)

  • 41. Acceptability of oral solid medicines in older adults with and without dysphagia: A nested pilot validation questionnaire based observational study.
    Liu F; Ghaffur A; Bains J; Hamdy S
    Int J Pharm; 2016 Oct; 512(2):374-381. PubMed ID: 26970368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE.
    Cox LS; Casale TB; Nayak AS; Bernstein DI; Creticos PS; Ambroisine L; Melac M; Zeldin RK
    J Allergy Clin Immunol; 2012 Dec; 130(6):1327-34.e1. PubMed ID: 23122534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The acceptability, efficacy and safety of a new paediatric oral suspension of roxithromycin in respiratory tract infections.
    Moniot-Ville N; Chelly M; Consten L; Rosenbaum M
    J Int Med Res; 1998; 26(3):144-51. PubMed ID: 9718469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sensory aspects of acceptability of bitter-flavoured 7.5 mm film-coated tablets in adults, preschool and school children.
    Hofmanová JK; Mason J; Batchelor HK
    Int J Pharm; 2020 Jul; 585():119511. PubMed ID: 32522503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of sublingual allergen vaccination for respiratory allergy in children. Conclusions from one meta-analysis.
    Olaguíbel JM; Alvarez Puebla MJ
    J Investig Allergol Clin Immunol; 2005; 15(1):9-16. PubMed ID: 15864877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early abortion with buccal versus sublingual misoprostol alone: a multicenter, randomized trial.
    Sheldon WR; Durocher J; Dzuba IG; Sayette H; Martin R; Velasco MC; Winikoff B
    Contraception; 2019 May; 99(5):272-277. PubMed ID: 30831103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Understanding the acceptability and adherence to paediatric antiretroviral treatment in the new formulation of pellets (LPV/r): the protocol of a realist evaluation.
    Nebot Giralt A; Nöstlinger C; Lee J; Salami O; Lallemant M; Ouma O; Nyamongo I; Marchal B
    BMJ Open; 2017 Mar; 7(3):e014528. PubMed ID: 28360249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanical bacterial lysate administration prevents exacerbation in allergic asthmatic children-The EOLIA study.
    Emeryk A; Bartkowiak-Emeryk M; Raus Z; Braido F; Ferlazzo G; Melioli G
    Pediatr Allergy Immunol; 2018 Jun; 29(4):394-401. PubMed ID: 29575037
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of recurrent respiratory tract infections with a polyvalent bacterial lysate: results of an open, prospective, multinational study.
    Grevers G; Palacios OA; Rodriguez B; Abel S; van Aubel A
    Adv Ther; 2000; 17(2):103-16. PubMed ID: 11010054
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain.
    Rauck RL; Tark M; Reyes E; Hayes TG; Bartkowiak AJ; Hassman D; Nalamachu S; Derrick R; Howell J
    Curr Med Res Opin; 2009 Dec; 25(12):2877-85. PubMed ID: 19814586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transmucosal administration of midazolam for premedication of pediatric patients. Comparison of the nasal and sublingual routes.
    Karl HW; Rosenberger JL; Larach MG; Ruffle JM
    Anesthesiology; 1993 May; 78(5):885-91. PubMed ID: 8489062
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet in Japanese children.
    Masuyama K; Okamoto Y; Okamiya K; Azuma R; Fujinami T; Riis B; Ohashi-Doi K; Natsui K; Imai T; Okubo K
    Allergy; 2018 Dec; 73(12):2352-2363. PubMed ID: 30043449
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Age-appropriate solid oral formulations for pediatric applications with a focus on multiparticulates and minitablets: Summary of September 2019 EuPFI workshop.
    Harris D; Hermans E; Klein S; Wagner-Hattler L; Walsh J
    Eur J Pharm Biopharm; 2020 Aug; 153():222-225. PubMed ID: 32580052
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical efficacy of sublingual immunotherapy tablets for allergic rhinitis is unlikely to be derived from
    Canonica GW; Devillier P; Casale T; Demoly P; Bos C; Karagiannis E; Passalacqua G; Wahn U; Mascarell L
    Expert Rev Clin Immunol; 2019 Sep; 15(9):921-928. PubMed ID: 31403823
    [No Abstract]   [Full Text] [Related]  

  • 55. [Acceptability, compliance and schedule of administration of oral antibiotics in outpatient children].
    Wollner A; Lécuyer A; De La Rocque F; Sedletzki G; Derkx V; Boucherat M; Elbez A; Gelbert-Baudino N; Levy C; Corrard F; Cohen R
    Arch Pediatr; 2011 May; 18(5):611-6. PubMed ID: 21420838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative evaluation of a new formulation of isosorbide dinitrate oral spray and sublingual nitroglycerin tablets.
    Marmor A
    Am J Cardiol; 1990 Jun; 65(21):43J-45J. PubMed ID: 2112337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of Grass Pollen Allergen Sublingual Immunotherapy Tablets for Seasonal Allergic Rhinoconjunctivitis: A Systematic Review and Meta-analysis.
    Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Di Lorenzo G
    JAMA Intern Med; 2015 Aug; 175(8):1301-9. PubMed ID: 26120825
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acceptability of Mini-Tablets in Young Children: Results from Three Prospective Cross-over Studies.
    Klingmann V
    AAPS PharmSciTech; 2017 Feb; 18(2):263-266. PubMed ID: 27714698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Age-appropriate and acceptable paediatric dosage forms: Insights into end-user perceptions, preferences and practices from the Children's Acceptability of Oral Formulations (CALF) Study.
    Ranmal SR; Cram A; Tuleu C
    Int J Pharm; 2016 Nov; 514(1):296-307. PubMed ID: 27863675
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Age-Appropriate Pediatric Dosage Forms in Japan: Insights into End-User Perceptions From an Observational Cross-Sectional Survey Assessing the Acceptability of Oral Formulation.
    Saito J; Akabane M; Komura M; Nakamura H; Ishikawa Y
    Ther Innov Regul Sci; 2019 Jul; 53(4):455-471. PubMed ID: 30157669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.